Immunogenicity 2451

summary
Sample ID
3942
Response
Negative
Tumor Type
Rectal cancer
Gene Symbol
ELAVL4
Transcript ID
uc010omz.2
HLA INFO
A*29:02
TCR INFO

No TCR info found!

T cell Tumor cell A*29:02
sequence
Full length protein sequence (371 aa)
MEWNG
1
LKMII
6
STMEP
11
QVSNG
16
PTSNT
21
SNGPS
26
SNNRN
31
CPSPM
36
QTGAT
41
TDDSK
46
TNLIV
51
NYLPQ
56
NMTQE
61
EFRSL
66
FGSIG
71
EIESC
76
KLVRD
81
KITGQ
86
SLGYG
91
FVNYI
96
DPKDA
101
EKAIN
106
TLNGL
111
RLQTK
116
TIKVS
121
YARPS
126
SASIR
131
DANLY
136
VSGLP
141
KTMTQ
146
KELEQ
151
LFSQY
156
GRIIT
161
SRILV
166
DQVTG
171
VSRGV
176
GFIRF
181
DKRIE
186
AEEAI
191
KGLNG
196
QKPSG
201
ATEPI
206
TVKFA
211
NNPSQ
216
KSSQA
221
LLSQL
226
YQSPN
231
RRYPG
236
PLHHQ
241
AQRFR
246
LDNLL
251
NMAYG
256
VKRFS
261
PITID
266
GMTSL
271
VGMNI
276
PGHTG
281
TGWCI
286
FVYNL
291
SPDSD
296
ESVLW
301
QLFGP
306
FGAVN
311
NVKVI
316
RDFNT
321
NKCKG
326
FGFVT
331
MTNYD
336
EAAMA
341
IASLN
346
GYRLG
351
DRVLQ
356
VSFKT
361
NKAHK
366
S
371
Mutation Information
DNA mutation:
None
Peptide Range:
213 ~ 237
Mut AA position:
225 (13 in Wild Type peptide)
Alignment
Wild Type:
"KFANNPSQKSSQALLSQLYQSPNRR
||||||||||||.||||||||||||
Mutant:
KFANNPSQKSSQSLLSQLYQSPNRR"
reference

Science, 2015

Immunogenicity of somatic mutations in human gastrointestinal cancers

Gene Name (from Reference) ELAVL4

clinic trial
Checkpoint Blockade

None

ACT

None

Vaccination

None

Curative Effect

None

experiment
minimal_peptide

None

Antigen Type

TMG RNA

T-cell Source

TILs

APC Type

autologous DCs

Assay

IFNg ELISPOT assay